U.S. Antibiotic Awareness Week

Katie J. Suda, PharmD, M.S., FCCP
Professor of Medicine and Pharmacy & Therapeutics
Associate Director, Center for Pharmaceutical Policy and Prescribing
University of Pittsburgh Schools of Medicine and Pharmacy

Dr. Suda is a Clinical Pharmacy Specialist, Core Investigator and Associate Director of Clinical Therapeutics with the VA Center for Health Equity Research and Promotion and Professor of Medicine and Pharmacy at the University of Pittsburgh Schools of Medicine and Pharmacy, Associate Director of the Center for Pharmaceutical Policy and Prescribing, and Director of the Transition to Independence Program. Dr. Suda is a national expert in outpatient prescribing patterns and antibiotic stewardship. Dr. Suda received a Doctor of Pharmacy degree from Drake University and a Master’s in epidemiology at the University of Tennessee. Dr. Suda’s post-doctoral training includes a residency at Baptist Memorial Health Care, a pharmacokinetics fellowship at the Clinical Pharmacokinetics Laboratory and an infectious diseases and outcomes research fellowship at the University of Illinois at Chicago.

• Describe antibiotic prescribing by dentists in the United States.
• Define appropriate indications for antibiotics for common dental indications.
• Discuss application of antibiotic stewardship in dentistry.

Mark Ferrey, BS, MS
Environmental Scientist, Minnesota Pollution Control Agency

Mark Ferrey is an environmental scientist at the Minnesota Pollution Control Agency where he has worked for 20 years. Before coming to the MPCA, he studied the microbial degradation of pesticides in soil at the University of Minnesota. Since then, he has focused on monitoring and understanding the fate of contaminants in the environment. He is currently studying pharmaceuticals and endocrine active compounds in Minnesota’s surface water. Mark has BS and MS degrees in microbiology and environmental science, both from the University of Minnesota.

• Learn what pharmaceuticals, including antibiotics, are found in surface water and at what concentrations.
• Identify pharmaceuticals and other contaminants that have been detected in fish.
• Describe the effects these chemicals may be having on fish and wildlife.

Jennifer Granick, DVM, PhD, DACVIM
Associate Professor of Small Animal Internal Medicine, University of Minnesota College of Veterinary Medicine
Topic: Tracking Antibiotic Use in Dogs and Cats: Methods for Data Collection, Summary of National Data, and Opportunities for Action

Jennifer Granick, DVM, PhD, Diplomate ACVIM is an associate professor of small animal internal medicine at the University of Minnesota College of Veterinary Medicine. Her research focuses on clinical antibiotic use and antimicrobial stewardship. She is Co-director of the Antimicrobial Resistance and Stewardship Initiative (ARSI) at the University of Minnesota and the Companion Animal Veterinary Surveillance Network. She chairs the University of Minnesota Veterinary Medical Center’s Antimicrobial Stewardship Committee.

Sandra Larson, DVM
Drug Residue Consultant and Outreach Veterinarian, Laboratory Evaluation Officer
Minnesota Department of Agriculture
Topic: Preventing Drug Residues in Minnesota Milk and Meat: Minnesota’s Drug Residue Prevention Program

Dr. Sandra Larson graduated from University of Minnesota Veterinary School. Before joining the Minnesota Department of Agriculture, she was in private practice for 23 years. Sandy's role with the Minnesota Department of Agriculture is as a Drug Residue Consultant and Outreach Veterinarian, and a Laboratory Evaluation Officer for milk screenings. She has conducted on-farm site visits for both tissue and milk residue violations.

• Understand the concept of pharmaceutical residues in food-animal products.
• Recognize the importance of the drug approval and labeling process, regulation of use, and on-farm practices to prevent meat and milk residues.
• Identify current methods available to track antibiotic use in companion animals, including dogs and cats.
• Summarize companion animal prescribing data available from two national FDA-funded surveys.
• Recognize data-driven opportunities to improve prescribing in companion animal practice.